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Evaluation of the Cortisol-to-ACTH Ratio in Dogs with
Hypoadrenocorticism, Dogs with Diseases Mimicking
Hypoadrenocorticism and in Healthy Dogs
F.S. Boretti, F. Meyer, W.A. Burkhardt, B. Riond, R. Hofmann-Lehmann, C.E. Reusch, and
N.S. Sieber-Ruckstuhl
Background: The adrenocorticotropic hormone (ACTH) stimulation test is the gold standard for diagnosing hypoadreno-
corticism (HA) in dogs. However, problems with the availability of synthetic ACTH (tetracosactrin/cosyntropin) and
increased costs have prompted the need for alternative methods.
Objectives: To prospectively evaluate the cortisol-to-ACTH ratio (CAR) as a screening test for diagnosing canine HA.
Animals: Twenty three dogs with newly diagnosed HA; 79 dogs with diseases mimicking HA; 30 healthy dogs.
Methods: Plasma ACTH and baseline cortisol concentrations were measured before IV administration of 5 lg/kg ACTH
in all dogs. CAR was calculated and the diagnostic performance of ACTH, baseline cortisol, CAR and sodium-to-potassium
ratios (SPRs) was assessed based on receiver operating characteristics (ROC) curves calculating the area under the ROC
curve.
Results: The CAR was signiﬁcantly lower in dogs with HA compared to that in healthy dogs and in those with diseases
mimicking HA (P < .0001). There was an overlap between HA dogs and those with HA mimicking diseases, but CAR still
was the best parameter for diagnosing HA (ROC AUC 0.998), followed by the ACTH concentration (ROC AUC 0.97), base-
line cortisol concentration (ROC AUC 0.96), and SPR (ROC AUC 0.86). With a CAR of >0.01 the diagnostic sensitivity
and speciﬁcity were 100% and 99%, respectively.
Conclusion and Clinical Importance: Calculation of the CAR is a useful screening test for diagnosing primary HA. As a
consequence of the observed overlap between the groups, however, misdiagnosis cannot be completely excluded. Moreover,
additional studies are needed to evaluate the diagnostic reliability of CAR in more dogs with secondary HA.
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Hypoadrenocorticism (HA) is an uncommon diseasein which adrenocortical steroid hormone secretion
falls below the physiological requirement of the animal.
Most aﬀected dogs suﬀer from primary HA. Usually,
primary HA results from immune-mediated destruction
of the adrenal cortex, which terminates in absolute deﬁ-
ciency of glucocorticoids and mineralocorticoids. Due
to the lack of negative feedback, high serum concentra-
tions of endogenous adrenocorticotropic hormone
(ACTH) accompany glucocorticoid deﬁciency. Second-
ary HA in dogs is rare and characterized by ACTH
deﬁciency with normal mineralocorticoid, but a lack of
glucocorticoid secretion.1
Dogs with HA can present with a range of nonspeciﬁc
signs.1–3 The most consistent biochemical abnormalities
include azotemia and electrolyte disturbances such
as hyponatremia, hyperkalemia, and a low sodium-
to-potassium ratio (SPR). Hyponatremia and hyper-
kalemia, although highly suspicious for HA, are neither
always present nor pathognomonic for the condition.4–8
Deﬁnitive diagnosis of HA requires an ACTH stimula-
tion test with synthetic ACTH (tetracosactrin or cosyn-
tropin). Recently, the availability of tetracosactrina has
become limited in Europe and, in some countries, costs
of synthetic ACTH have dramatically increased. This sit-
uation has prompted a need for alternative tests with
which to diagnose HA. Measurement of baseline cortisol
concentration has been shown to be a useful screening
test to rule out HA.9,10 The disease is unlikely with a
baseline serum cortisol >2 lg/dL (>55 nmol/L).9,10 How-
ever, due to that test’s rather low speciﬁcity, an ACTH
stimulation test must be performed in dogs with a base-
line cortisol ≤2 lg/dL to safely exclude HA.9,10
Calculation of the cortisol-to-ACTH ratio (CAR) has
been evaluated in previous studies and seems to be a
promising tool to diagnose HA.11,12 The only study that
included a group of dogs with nonadrenal disease,
however, had a retrospective design, the number of
animals per group was relatively low, and no dog with
secondary HA was included.12
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The purpose of this study was to prospectively evalu-
ate the CAR in a larger group of dogs with the main
focus on the comparison of the CAR between dogs with
HA and dogs with diseases mimicking HA. Our
hypothesis was that CAR would prove to have good
diagnostic value in diﬀerentiating dogs with HA from
those with diseases mimicking HA, but that overlaps
would occur. In addition, receiver operating characteris-
tic (ROC) curves of the CAR, plasma ACTH concen-
tration, baseline cortisol concentration and SPR were
determined and the area under the curve (AUC) calcu-
lated to evaluate which would be the best single labora-
tory test for diagnosing HA in dogs.
Material and Methods
Animals and Study Design
Twenty three client-owned dogs with newly diagnosed HA were
prospectively enrolled between December 2008 and September
2014. Diagnostic evaluation included CBC, serum biochemical
proﬁle, urinalysis, ACTH stimulation test, abdominal ultrasonog-
raphy with particular attention to the adrenal glands, and mea-
surement of endogenous plasma ACTH concentration in all dogs.
Dogs previously treated with glucocorticoids, mineralocorticoids,
progestagens, or trilostane were excluded from the study. Hypoad-
renocorticism was conﬁrmed by a subnormal ACTH-stimulated
serum cortisol concentration after 60 minutes (<2 lg/dL) in 22
dogs. One dog had a baseline serum cortisol concentration of
2.0 lg/dL and a post-ACTH cortisol concentration of 2.6 lg/dL.
The endogenous ACTH concentration was >1250 pg/mL and the
sodium and potassium concentrations were 114 and 8.3 mmol/L,
respectively (reference range: sodium, 151–160 mmol/L; potassium,
4.2–5.4 mmol/L). Cross-reactivity due to prior steroid treatment
could be deﬁnitively excluded.
Seventy nine dogs with diseases mimicking HA diagnosed
between October 2008 and October 2014 were prospectively
enrolled in the study. All dogs initially had been suspected of hav-
ing HA on the basis of clinical signs or laboratory ﬁndings rou-
tinely seen in dogs with HA, such as vomiting, diarrhea,
weakness, lethargy, hyperkalemia, hyponatremia, or some combi-
nation of these. An ACTH stimulation test was performed after
blood collection to determine plasma ACTH concentration in all
dogs and a diﬀerent ﬁnal diagnosis was made in each dog. All
dogs had an ACTH-stimulated serum cortisol concentration
≥5 lg/dL.
Ten privately owned dogs and 20 purpose-bred research dogs
(12 mixed breed and 8 Beagles) were used as controls. The dogs
were considered to be healthy on the basis of a normal history
and physical examination, as well as hematology and serum bio-
chemistry proﬁle results within the normal reference interval. An
abdominal ultrasound examination was not included in the diag-
nostic evaluation of the healthy dogs. Baseline serum cortisol and
plasma ACTH concentrations were measured in all dogs. An
ACTH stimulation test was performed in all privately owned and
all mixed breed research dogs, but not in the 8 research Beagles.
Hypoadrenocorticism was excluded either by a post-ACTH serum
cortisol concentration ≥5 lg/dL (in the privately owned dogs and
the mixed breed research dogs) or a baseline serum cortisol con-
centration >2 lg/dL (in the research Beagles).
All procedures were approved by the Cantonal Veterinary
Oﬃce of Zurich (permission number: 133/2013) and conducted in
accordance with guidelines established by the Animal Welfare Act
of Switzerland. In addition, informed consent was obtained from
the owners of the healthy dogs.
Analytical Procedures
For the ACTH stimulation test, blood samples were taken
before and 60 min after IV injection of 5 lg/kg synthetic ACTH.a
Serum cortisol concentrations were measured by chemilumines-
cence assay.b Sensitivity of the cortisol assay was 0.2 lg/dL.
Plasma endogenous ACTH concentration before ACTH stimula-
tion was determined by a chemiluminescence assay.b Blood was
collected into chilled EDTA-coated tubes, placed on ice, and cen-
trifuged at 4°C. Cortisol and endogenous ACTH measurements
were performed in house twice a week; plasma was stored either at
20°C (cortisol) or at 80°C (ACTH) until assayed.
Statistical Analysis
Statistical analysis was performed using commercial software by
using nonparametric tests.c,d,e Data are expressed as median and
range. Diﬀerences between groups were tested by use of the
Kruskal–Wallis H-test and Dunn’s post test. The cut-oﬀ for vari-
ous variables to discriminate between dogs with and without HA
was determined by positive/negative likelihood ratios based on
ROC curves. Diagnostic eﬃcacy was assessed by calculating the
area under the ROC curve (AUC). For results below the detection
limit, the mean between 0 and the detection limit was entered for
statistical analysis; for ACTH concentrations >1250, 1251 pg/mL
was entered for statistical analysis. The level of signiﬁcance was
set at P < .05.
Results
Animals
In the dogs with HA, age ranged from 0.8 to 10 years
(median, 5 years) and body weight from 1.9 to 30.4 kg
(median, 10.4 kg). There were 10 males (4 castrated)
and 13 females (11 spayed). The HA group consisted of
17 purebred dogs and 6 mixed breed dogs. Twenty two
dogs were diagnosed with primary HA and 1 dog was
diagnosed with secondary HA.
In the dogs with diseases mimicking HA, age ranged
from 0.3 to 15 years (median, 4 years) and body weight
from 1.7 to 67 kg (median, 24 kg). There were 46 males
(23 castrated) and 33 females (20 spayed). This group
consisted of 71 purebred dogs and 8 mixed breed dogs.
The ﬁnal diagnoses were acute gastroenteritis (28),
chronic intermittent gastroenteritis (9), urinary disease
(5), colitis (3), hypothyroidism (3), megaesophagus (2),
psychogenic polydipsia (2), pancreatic disease (1), intesti-
nal perforation and septic abdomen (1), stomach over-
load (1), myasthenia gravis (1), laryngeal paralysis (1),
insulinoma (1), muscular dystrophy (1), acetaminophen
intoxication (1), and other ambiguous diseases (19).
In the healthy dogs, age ranged from 0.8 to 12 years
(median, 1.75 years) and bodyweight from 6.9 to 27 kg
(median, 15 kg). There were 13 males (0 castrated) and
17 females (5 spayed). In all, 16 purebred dogs and 14
mixed breed dogs were included.
Baseline Serum Cortisol Concentrations
Results of baseline serum cortisol concentrations in
dogs with HA, in those with diseases mimicking HA
and in healthy dogs are summarized in Table 1. Base-
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line serum cortisol concentrations were signiﬁcantly
lower in dogs with HA than in dogs with diseases mim-
icking HA and in healthy dogs (P < .0001 and
P < .0001). There was distinct overlap among the 3
groups (Fig 1). There was no diﬀerence between the
baseline serum cortisol concentrations of dogs with dis-
eases mimicking HA and healthy dogs (Fig 1).
Endogenous Plasma Concentrations ACTH (ACTH)
Results of plasma ACTH concentrations in dogs with
HA, in those with diseases mimicking HA and in healthy
dogs are summarized in Table 1. Plasma ACTH concen-
trations were signiﬁcantly higher in dogs with HA than in
dogs with diseases mimicking HA and in healthy dogs
(P < .0001 and P < .0001). There was no diﬀerence
between the plasma ACTH concentrations of dogs with
diseases mimicking HA and those of healthy dogs (Fig 2).
Two dogs with HA had plasma ACTH concentra-
tions in the range of healthy dogs or in the range of
those with diseases mimicking HA (ACTH concentra-
tions, 22 and 30 pg/mL; Fig 2).
In 1 of the dogs, serum sodium and potassium
concentrations were 122 and 7.3 mmol/L, respectively
(reference range: sodium, 151–160 mmol/L; potassium,
4.2–5.4 mmol/L). Serum cortisol and aldosterone con-
centrations before and 1 hour after ACTH stimulation
were below the detection limits of the assays. Due to
the severe electrolyte abnormalities and undetectable
aldosterone concentrations, this dog was diagnosed with
primary HA and treated with mineralocorticoid and
glucocorticoid supplementation.
In the other dog, serum sodium and potassium concen-
trations were 147 and 4.3 mmol/L, respectively. Cortisol
concentrations (before and 1 hour after ACTH stimula-
tion) were undetectable, baseline aldosterone concentra-
tion was low (3.2 pg/mL) and serum renin activity was in
the low reference range (0.45 ng/mL/h), which seemed
consistent with secondary HA.13 This dog was treated
with glucocorticoids only; 1.5 years later the dog was
completely stable on glucocorticoid treatment alone.
One dog with disease mimicking HA had a plasma
ACTH concentration in the range of dogs with HA
(1069 pg/mL, Fig 2). In this dog, serum sodium and potas-
sium concentrations were 130 and 3.5 mmol/L, respectively.
The dog ﬁnally was diagnosed with acute kidney injury and
HA was excluded on the basis of a post-ACTH serum corti-
sol concentration of 8.6 lg/dL.
Cortisol-to-ACTH Ratio
Results of the CAR of dogs with HA, those with
diseases mimicking HA and all healthy dogs are
Table 1. Median an range of cortisol-to-adrenocorticotropic hormone (ACTH)-ratio (CAR), endogenous ACTH
(ACTH), baseline cortisol, and sodium-to-potassium ratio (SPR) of 23 dogs with HA, 79 dogs with diseases mimick-
ing HA and in 30 healthy dogs.
Dogs with Hypoadrenocorticism
Dogs with Diseases
Mimicking HA Healthy Dogs
Range Median Range Median Range Median
CAR 0.00016–0.009 0.00028 0.001–0.37 0.076 0.03–0.38 0.078
ACTH (pg/mL) 22–>1250 945 <10–1069 20 <10–38 18
Baseline cortisol (lg/dL) <0.2–2 <0.2 <0.2–9.3 1.5 0.6–12 1.35
SPR 13.3–34.6 23.6 20.7–47.6 32.6 31.9–37.3 34.1
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Fig 1. Scatter scale plot comparing baseline serum cortisol con-
centrations of dogs with hypoadrenocorticism (HA, n = 23), dogs
with diseases mimicking HA (mimicking HA, n = 79) and healthy
dogs (healthy, n = 30). The horizontal bars represent the median
of each group.
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Fig 2. Scatter log scale plot comparing plasma adrenocorti-
cotropic hormone (ACTH) concentrations of dogs with hypoad-
renocorticism (HA, n = 23), dogs with diseases mimicking HA
(mimicking HA, n = 79) and healthy dogs (healthy, n = 30). The
horizontal bars represent the median of each group.
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summarized in Table 1. The CAR was signiﬁcantly
lower in dogs with HA compared to dogs with diseases
mimicking HA and healthy dogs (P < .0001 and
P < .0001). There was no diﬀerence between the CAR
of dogs with diseases mimicking HA and healthy dogs
(Fig 3). One dog in the group with diseases mimicking
HA had a CAR in the range of the HA dogs (Fig 3).
This dog was the 1 described above with the markedly
increased plasma ACTH concentration and a ﬁnal
diagnosis of acute kidney injury.
Sodium-to-Potassium Ratio
Results of the SPR ratio in dogs with HA, those with
diseases mimicking HA and healthy dogs are summa-
rized in Table 1. The SPR ratio was signiﬁcantly lower
in dogs with HA than in dogs with diseases mimicking
HA and healthy dogs (P < .0001 and P < .0001), but
considerable overlap was observed. There was no diﬀer-
ence between the SPR of dogs with diseases mimicking
HA and healthy dogs (Fig 4).
Of the 23 dogs with HA, 3 dogs had both serum
sodium and potassium concentrations within the normal
reference range, 16 dogs had hyponatremia combined
with hyperkalemia and 4 dogs had hyponatremia (1
with secondary HA).
Serum sodium and potassium concentrations at initial
presentation were available in 71 dogs with diseases
mimicking HA. Forty one dogs had both electrolytes
within the normal reference range, 3 dogs had hypona-
tremia combined with hyperkalemia, 20 dogs had
hyponatremia, and 7 dogs hyperkalemia.
ROC Analysis
The AUC of the ROC was largest for the CAR, fol-
lowed by ACTH, baseline cortisol and SPR (Fig 5).
Table 2 shows the AUCs and their 95% conﬁdence inter-
vals. The AUC of CAR and ACTH were signiﬁcantly
larger than the AUC of SPR (P = .006 and P = .04)
(Table 2). There was no signiﬁcant diﬀerence between the
AUC of baseline cortisol and SPR. In addition, the AUC
of CAR, ACTH, and baseline cortisol did not signiﬁ-
cantly diﬀer from 1 another.
Maximizing both the sensitivity and the speciﬁcity of
the variables yielded cut-oﬀ values of >0.01 for the
CAR and >2 lg/dL for baseline cortisol to exclude HA
and >178 pg/mL for ACTH and ≤24 for SPR to
conﬁrm HA. Table 3 shows the cut-oﬀ values for each
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Fig 3. Scatter log scale plot comparing cortisol-to-adrenocorti-
cotropic hormone (ACTH) ratios of dogs with hypoadrenocorti-
cism (HA, n = 23), dogs with diseases mimicking HA (mimicking
HA, n = 79) and healthy dogs (healthy, n = 30). The horizontal
bars represent the median of each group.
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Fig 4. Scatter scale plot comparing sodium-to-potassium ratios of
dogs with hypoadrenocorticism (HA, n = 23), dogs with diseases
mimicking HA (mimicking HA, n = 79) and healthy dogs (healthy,
n = 30). The horizontal bars represent the median of each group.
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Fig 5. Receiver operating characteristic curves of cortisol-to-
adrenocorticotropic hormone (ACTH) ratio (CAR), ACTH, base-
line cortisol and sodium-to-potassium ratio (SPR) for the prediction
of hypoadrenocorticism (HA). The more closely the curve follows
the left and top borders of the receiver operating characteristic
(ROC) space, the more accurate is the test.
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of the variables as well as their diagnostic sensitivity
and speciﬁcity.
Discussion
Dogs with HA had a signiﬁcantly lower CAR than
did dogs with diseases mimicking HA and healthy dogs.
This result is in accordance with previous observa-
tions.11,12 However, in those 2 previous studies, there
was no overlap between the diﬀerent groups, making
CAR a more than ideal test for diagnosing HA. In con-
trast, our study showed an overlap of CAR values
among the diﬀerent groups. In a previous study, dogs
with HA only were compared to healthy dogs (ie, a
group of dogs with nonadrenal disease was not
included).11 Another study included dogs with nona-
drenal disease, but the number of animals per group
was lower than in our study.12 In addition, no dog with
secondary HA was included, although many of their
dogs with HA did not have electrolyte abnormalities. In
one-third of the dogs in their study, plasma ACTH con-
centration was not determined at the same time as base-
line serum cortisol concentration or ACTH stimulation
test. Instead, plasma was collected 12–24 hours after
stimulation. Our study was designed prospectively and
standardization of sample collection was a prerequisite
(inclusion criteria).
Despite some overlap of the CAR among the diﬀer-
ent groups in this study, CAR still was the single best
test for diagnosing HA with a diagnostic sensitivity of
100% and a speciﬁcity of 99%, using a CAR cut-oﬀ
ratio of >0.01. With this cut-oﬀ, only 1 dog would have
been falsely diagnosed with HA (CAR, 0.001). This dog
had a very high plasma ACTH concentration (1069 pg/
mL) and without results of the ACTH stimulation test
would have been misdiagnosed with HA and have
received lifelong treatment. However, HA was reliably
excluded based on a normal ACTH stimulation test and
on follow-up of 1.5 years without any clinical signs
compatible with HA. Explaining the markedly increased
plasma ACTH concentration in this dog is diﬃcult. The
dog appeared normal at presentation and did not seem
overtly stressed. One speculative explanation could be
the administration of a short-acting corticosteroid (eg,
prednisolone succinate, hydrocortisone) just days before
referral by a private veterinarian. Cessation of cortico-
steroids can lead to a rebound increase in ACTH.
Although plasma ACTH concentrations observed in
experimental Beagle dogs treated with hydrocortisone
were increased after cessation of treatment, their
concentrations did not reach the magnitude of ACTH
concentration observed in our dog (Schellenberg S,
Glaus T.M., Reusch C. E. unpublished data).
Two dogs with HA had a high CAR (0.009 and
0.0067) due to rather low ACTH concentrations (22
and 30 pg/mL). One of these dogs was presented during
an hypoadrenal crisis with severe electrolyte abnormali-
ties (serum sodium concentration, 122 mmol/L; serum
potassium concentration, 7.6 mmol/L). Approximately
5 months later, the dog was presented again, severely
sick and with serum electrolyte abnormalities (serum
sodium concentration, 143 mmol/L; serum potassium
concentration, 10.8 mmol/L) because the owner had
discontinued the dog’s mineralocorticoid and glucocor-
ticoid supplementation. The dog therefore was diag-
nosed with primary HA (undetectable serum cortisol
and aldosterone concentrations). Glucocorticoid treat-
ment with ongoing eﬀect by the referring veterinarian
could have suppressed the ACTH concentration, but
this could be reliably excluded. Improper sample han-
dling leading to degradation of ACTH could be another
explanation. However, because our sample handling for
ACTH measurement is standardized (eg, rapid process-
ing, continuous cooling immediately after blood sam-
pling) this possibility seems unlikely. The other dog
with a high CAR was diagnosed with secondary HA.
This dog had a mild hyponatremia (serum sodium con-
centration, 147 mmol/L; most likely caused by sodium
loss as a result of progressive vomiting for 1 week) and
1.5 years later was completely stable on glucocorticoid
treatment alone.
In a recent study, in which the CAR was evaluated
as a diagnostic test for HA, no dog with secondary HA
was included.12 The authors speculated that the CAR
values would be expected to be much higher than those
of dogs with primary HA. At least for the 1 dog of our
study with secondary HA this speculation seems correct.
However, the CAR of the 1 dog with secondary HA in
our study still was lower than the CAR results of
healthy dogs or dogs with diseases mimicking HA. Very
few cases of secondary HA in which ACTH concentra-
Table 2. Area under the receiver operating characteris-
tic curves (AUC) and 95 per cent conﬁdence interval of
the cortisol-to-ACTH ratio (CAR), ACTH concentra-
tion, baseline cortisol and sodium-to-potassium ratio
(SPR).
Value AUC 95% CI
CARa 0.998 0.958–1.000
ACTHa 0.97 0.910–0.993
Baseline cortisola,b 0.96 0.894–0.988
SPRb 0.86 0.775–0.924
a,bDiﬀerent letters indicate statistically signiﬁcant diﬀerence
between groups (P < .05).
Table 3. Cut-oﬀ values and maximized sensitivity and
speciﬁcity to exclude (CAR, baseline cortisol) or con-
ﬁrm (ACTH, SPR) HA derived from the two-graph
receiver operating characteristic analysis.
Value
Cut-oﬀ
Value
Sensitivity
(%) 95% CI
Speciﬁcity
(%) 95% CI
CAR >0.01 100 85–100 99 93–100
Baseline
cortisol
(lg/dL)
>2 100 85–100 20 13–32
ACTH
(pg/mL)
>178 91 72–99 99 93–100
SPR ≤24 56 35–77 99 93–100
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tions were measured could be identiﬁed in the veteri-
nary literature.1,14–16 In only 1 of these cases could the
CAR be calculated, because in the others either baseline
serum cortisol concentrations of 1 individual dog could
not be extracted from their results or plasma ACTH
concentration was reported to be 0. In the 1 other dog
with secondary HA, baseline serum cortisol concentra-
tion was 0.21 lg/dL and plasma ACTH concentration
was 9.9 pg/mL, resulting in a CAR of 0.02.16 In our
study, this CAR value would fall into the CAR range
of dogs with diseases mimicking HA. In the previous
study, this CAR would be in the CAR range of dogs
with HA.12 These ﬁndings emphasized 2 important
points: ﬁrst, overlap between CAR results of dogs with
HA (especially dogs with secondary HA) and of dogs
with diseases mimicking HA can occur, which decreases
the reliability of the CAR to diagnose HA; and, second,
care should be taken in adopting CAR results from the
literature for the diagnosis of HA. Comparing CAR
results from 1 study to another shows striking diﬀer-
ences; Upper values of dogs with HA in the 2 published
studies were 0.17 and 0.03111,12 compared to 0.009 in
our study. It might be reasonable to assume that the
most likely explanation for the observed discrepancies is
the diﬀerent assay systems (radioimmunoassay versus
chemiluminescence assay) used for the determination of
ACTH and cortisol. Interestingly, the same chemilumi-
nescence assay (Immulite) was used in 1 previous study
as in our study and, even so, CAR results were approxi-
mately 3.5 times higher in the previous study.12 Adopt-
ing a published CAR value can lead to decreased
sensitivity and a missed diagnosis, which can be poten-
tially fatal in dogs with HA. Consequently, clinician
should be very careful when comparing values among
diﬀerent studies. It would be advisable to establish ref-
erence values not only for each assay system (cortisol
and ACTH) but also for each laboratory that oﬀers the
assays. Furthermore, the reliability of CAR to diagnose
secondary HA must be evaluated in a larger group of
dogs.
Determination of baseline serum cortisol concentra-
tion has a high sensitivity (100% if >2 lg/dL) to
exclude HA, but a low speciﬁcity of only 63.3–
78.2%.9,10 In our study, although having the same sen-
sitivity of 100%, its speciﬁcity was only 20%. Median
baseline serum cortisol concentrations were 1.35 lg/dL
in the healthy dogs and 1.5 lg/dL in those with disease
mimicking HA, meaning that at least 50% of our con-
trol population (healthy dogs and dogs with diseases
mimicking HA) had baseline serum cortisol concentra-
tions below the suggested optimal cut-oﬀ of 2 lg/dL.
Several explanations must be taken into account. First,
we had a rather high percentage of experimental dogs
in the healthy controls. They were adapted to blood
sampling and blood was not taken in the hospital but
in their natural environment (research facility). The
most plausible explanation for the observed rather low
baseline serum cortisol concentrations in the healthy
and nonadrenal disease group seems to be the diﬀer-
ence in the assay system used, as discussed above.
Wide variations in cortisol concentrations can occur
for the same sample measured by diﬀerent laboratories
and even using the same commercially available assay
(Extended Quality Assessment of the Society for Com-
parative Endocrinology [SCE] and the European Soci-
ety for Veterinary Endocrinology [ESVE], unpublished
data).
Determination of ACTH in the diagnosis of HA is
mainly used in dogs with normal serum electrolyte con-
centrations to diﬀerentiate primary from secondary HA.
Although in primary HA plasma ACTH concentration
would be expected to be increased, in secondary HA
concentrations within or even below the reference range
would conﬁrm the diagnosis. This variable also has
been evaluated as a screening test for HA; but, overlap
between the groups (HA, diseases mimicking HA) is
more pronounced than with the CAR. One study, using
plasma ACTH concentration of >50 pg/mL as the best
calculated cut-oﬀ, resulted in a sensitivity of 96% and a
speciﬁcity of 100%.16 Evaluating plasma ACTH con-
centration as single variable in our study also showed
overlap among the groups, resulting in a sensitivity of
only 91% and a speciﬁcity of 99% using the best calcu-
lated cut-oﬀ concentration of >178 pg/mL. The main
limitation of ACTH measurement in practice is the
instability of the hormone. To avoid degradation blood
must be collected in precooled EDTA plastic tubes, pro-
cessed immediately without cessation of cooling and
frozen until analysis. This procedure is time-consuming
and cost-intensive. However, depending on cost devel-
opment and availability of synthetic ACTH, determina-
tion of ACTH may become practical for practitioners
in the future.
Although a low SPR is highly suspicious for HA,
there are several other conditions such as Trichuris vul-
pis infection, other gastrointestinal problems, renal, or
cardiorespiratory problems and ascites that also are
associated with hyperkalemia and concurrent hypona-
tremia.4–8 In our study, using the best calculated cut-oﬀ
ratio of ≤24 resulted in a speciﬁcity of 99% and a sensi-
tivity of only 56% for diagnosing HA. Compared to a
recent study16 that showed a sensitivity of 92% and a
speciﬁcity of 91% with a best calculated cut-oﬀ of ≤22,
our sensitivity is markedly lower. Several earlier studies
have evaluated SPR as a diagnostic test in dogs in
which HA is suspected.1,17,18 In none of them was there
convincing evidence that SPR could be a reliable test,
either to conﬁrm or exclude the diagnosis. Not all dogs
with HA have electrolyte abnormalities and only a
minority of dogs with decreased SPR do indeed have
HA.1,17
In conclusion, determination of CAR in dogs sus-
pected of primary HA is a valuable and reliable tool
with which to exclude or conﬁrm the diagnosis. The
greatest advantage is the need for only a single blood
sample from which both serum cortisol and plasma
ACTH concentrations can be measured. Unlike ﬁndings
in a previous study, diﬀerentiation between dogs with
HA and those with diseases mimicking HA was not
100%, based on the present results. In addition, the
reliability of the CAR in diagnosing secondary HA
needs to be evaluated in future.
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